Best GLP-1 Providers in Ohio (2026)

See by medication

Looking for a specific GLP-1? Browse Ohio providers by drug.

About GLP-1s in Ohio

Ohio permits telehealth GLP-1 prescribing. Ohio Medicaid covers GLP-1s only for type 2 diabetes diagnosis.

• •Ohio's adult obesity rate is 35.5%
• •Ohio Medicaid limits GLP-1 coverage to diabetes
• •Columbus and Cleveland are major Midwest telehealth markets

Top Cities for GLP-1 Treatment in Ohio

Telehealth providers ship to all Ohio addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Ohio GLP-1 clinic directory →

GLP-1 Care Access in Ohio: The Numbers

Ohio has 958 NPI-registered in-person weight-management clinics across 182 cities — 18 with an obesity-medicine taxonomy, 450 endocrinology, and 506 bariatric — alongside 98 telehealth programs that ship to Ohio addresses. The cheapest verified ongoing compounded semaglutide price available to Ohio residents is $79/mo (tirzepatide: $97/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in Ohio

In Q1 2026, Ohio Medicaid reimbursed approximately $88,436,157 across 90,596 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in Ohio cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $189/mo.

For the exact criteria, drug list, and appeal process, read our Ohio Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Ohio

According to CDC data, 35.5% of Ohio adults have obesity (BMI of 30 or higher). This places Ohio at #11 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Ohio residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions